000 01343 a2200385 4500
005 20250516193924.0
264 0 _c20150110
008 201501s 0 0 eng d
022 _a1879-0305
024 7 _a10.1016/j.cytogfr.2014.01.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSigl, Verena
245 0 0 _aRANKL/RANK - from bone physiology to breast cancer.
_h[electronic resource]
260 _bCytokine & growth factor reviews
_cApr 2014
300 _a205-14 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAutoimmune Diseases
_xgenetics
650 0 4 _aBone Diseases
_xmetabolism
650 0 4 _aBone Neoplasms
_xpathology
650 0 4 _aBone and Bones
_xmetabolism
650 0 4 _aBreast Neoplasms
_xpathology
650 0 4 _aCell Transformation, Neoplastic
_xgenetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aNF-kappa B
_xgenetics
650 0 4 _aOsteoporosis
650 0 4 _aOsteoprotegerin
_xgenetics
650 0 4 _aRANK Ligand
_xphysiology
650 0 4 _aReceptor Activator of Nuclear Factor-kappa B
_xphysiology
700 1 _aPenninger, Josef M
773 0 _tCytokine & growth factor reviews
_gvol. 25
_gno. 2
_gp. 205-14
856 4 0 _uhttps://doi.org/10.1016/j.cytogfr.2014.01.002
_zAvailable from publisher's website
999 _c23506583
_d23506583